PCN137 COST COMPARISON OF ADVERSE EVENTS AND TREATMENT ADMINISTRATION OF LURBINECTEDIN VERSUS INTRAVENOUS TOPOTECAN FOR RELAPSED SMALL CELL LUNG CANCER IN SPAIN AND THE UNITED KINGDOM

Value in Health ◽

10.1016/j.jval.2019.09.333 ◽

2019 ◽

Vol 22 ◽

pp. S462

Author(s):

B. García San Andrés ◽

S. Ubi ◽

R. Alvarez-Alvarez ◽

C. Barwood ◽

M.E. Olmedo-García ◽

...

Keyword(s):

Lung Cancer ◽

United Kingdom ◽

Adverse Events ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Cost Comparison ◽

Small Cell Lung ◽

The United Kingdom ◽

Treatment Administration

Download Full-text

Treatment patterns in patients with advanced non-small cell lung cancer (aNSCLC): real-world data from the United Kingdom

Lung Cancer ◽

10.1016/s0169-5002(20)30137-9 ◽

2020 ◽

Vol 139 ◽

pp. S47-S48

Author(s):

J. Lester ◽

S. Khan ◽

C. Powell ◽

C. Escriu ◽

E. Hudson ◽

...

Keyword(s):

Lung Cancer ◽

United Kingdom ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Real World ◽

Treatment Patterns ◽

Small Cell ◽

Small Cell Lung ◽

Real World Data ◽

The United Kingdom

Download Full-text

1379P Real-world (RW) clinical outcomes of patients with metastatic non-small cell lung cancer (mNSCLC) in the United Kingdom

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1693 ◽

2020 ◽

Vol 31 ◽

pp. S878-S879

Author(s):

J. Lester ◽

C. Escriu ◽

S. Khan ◽

E. Hudson ◽

T. Mansy ◽

...

Keyword(s):

Lung Cancer ◽

United Kingdom ◽

Small Cell Lung Cancer ◽

Clinical Outcomes ◽

Cell Lung Cancer ◽

Real World ◽

Small Cell ◽

Small Cell Lung ◽

The United Kingdom

Download Full-text

Contemporary non-small cell lung cancer practice in the United Kingdom

Clinical Oncology ◽

10.1016/j.clon.2004.04.005 ◽

2004 ◽

Vol 16 (5) ◽

pp. 379-380 ◽

Cited By ~ 2

Author(s):

M Dahele

Keyword(s):

Lung Cancer ◽

United Kingdom ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

The United Kingdom

Download Full-text

Cost-Effectiveness of Ceritinib In Previously Untreated ALK-Positive Non-Small Cell Lung Cancer in the United Kingdom

Value in Health ◽

10.1016/j.jval.2018.04.182 ◽

2018 ◽

Vol 21 ◽

pp. S29

Author(s):

J Xie ◽

S Knoll ◽

A Slowley ◽

A Bensimon ◽

J Vieira ◽

...

Keyword(s):

Lung Cancer ◽

United Kingdom ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

The United Kingdom ◽

Alk Positive

Download Full-text

Cost-Effectiveness of Erlotinib versus Docetaxel for Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer in the United Kingdom

Journal of International Medical Research ◽

10.1177/147323001003800102 ◽

2010 ◽

Vol 38 (1) ◽

pp. 9-21 ◽

Cited By ~ 34

Author(s):

G Lewis ◽

M Peake ◽

R Aultman ◽

M Gyldmark ◽

L Morlotti ◽

...

Keyword(s):

Lung Cancer ◽

United Kingdom ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Second Line ◽

Small Cell Lung ◽

The United Kingdom

Download Full-text

A national survey of the chemotherapy regimens used to treat small cell lung cancer (SCLC) in the United Kingdom

British Journal of Cancer ◽

10.1054/bjoc.2001.1817 ◽

2001 ◽

Vol 84 (11) ◽

pp. 1447-1452 ◽

Cited By ~ 19

Author(s):

R J Sambrook ◽

D J Girling

Keyword(s):

Lung Cancer ◽

United Kingdom ◽

Small Cell Lung Cancer ◽

National Survey ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

The United Kingdom

Download Full-text

Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS)

Lung Cancer ◽

10.1016/j.lungcan.2018.06.007 ◽

2018 ◽

Vol 124 ◽

pp. 298-309 ◽

Cited By ~ 7

Author(s):

Stefan Andreas ◽

Christos Chouaid ◽

Sarah Danson ◽

Obukohwo Siakpere ◽

Laure Benjamin ◽

...

Keyword(s):

Lung Cancer ◽

United Kingdom ◽

Observational Study ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Economic Burden ◽

Small Cell ◽

Small Cell Lung ◽

The United Kingdom ◽

Resected Stage

Download Full-text

An overview of prognostic factors in small cell lung cancer. A report from the Subcommitte for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research

Lung Cancer ◽

10.1016/0169-5002(91)90153-w ◽

1991 ◽

Vol 7 (3) ◽

pp. 191-192

Keyword(s):

Lung Cancer ◽

Cancer Research ◽

United Kingdom ◽

Prognostic Factors ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

The United Kingdom

Download Full-text

1337P The clincial utility of circulating free DNA (cfDNA) analysis in non-small cell lung cancer (NSCLC) in the United Kingdom

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1651 ◽

2020 ◽

Vol 31 ◽

pp. S859

Author(s):

A. Greystoke ◽

M. Carter ◽

W. Griffiths ◽

G. Laviste ◽

A. Ortega-Franco ◽

...

Keyword(s):

Lung Cancer ◽

United Kingdom ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Circulating Free Dna ◽

The United Kingdom ◽

Free Dna

Download Full-text

CN5 EXPLORATORY ECONOMIC EVALUATION OF ADJUVANT TREATMENT OF NON-SMALL-CELL LUNG CANCER (NSCLC) WITH BEVACIZUMAB IN ADDITION TO A CISPLATIN-BASED TREATMENT REGIMEN IN THE UNITED KINGDOM

Value in Health ◽

10.1016/s1098-3015(10)66228-6 ◽

2008 ◽

Vol 11 (6) ◽

pp. A357

Author(s):

M Gyldmark ◽

U Gatzemeier ◽

M Nicolson ◽

N Latimer ◽

S Walzer

Keyword(s):

Lung Cancer ◽

United Kingdom ◽

Economic Evaluation ◽

Small Cell Lung Cancer ◽

Treatment Regimen ◽

Cell Lung Cancer ◽

Adjuvant Treatment ◽

Small Cell ◽

Small Cell Lung ◽

The United Kingdom

Download Full-text